An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease | MicrobiomeTrials← Back to trialsNCT07724132
An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-07-24Est. Completion: 2031-03
Enrollment target: 1,200 participants Locations- Windsor Research Unit, Cambridge, United Kingdom
- Two Bridges Research & Development Clinic, Chertsey, United Kingdom
Other microbiome trials you might be interested in
MCI-AD, Early Stage Alzheimer's DiseaseAlzheimer s DiseaseMild Cognitive Impairment (MCI) AmnesticADAD-MCI
This proof-of-concept study explores whether long-term home-based closed-loop auditory stimulation during sleep enhances…
Zaragoza, SpainCompleted Nov 30, 2026
Alzheimer s DiseaseMild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseMild Dementia
The goal of this clinical trial is to learn if repetitive transcranial magnetic stimulation (rTMS), a non-invasive form …
Houston, United States
Est. completion Apr 14, 2031